Free Shipping on purchases over €100

Avene Sunisimed Pigment, 80 ml

Avène Sunisimed AV Pigment, 80 ml

Avene Sunisimed Pigment is a sun cream specialised in the protection and prevention of pigmentation spots with SPF50+, ideal for sensitive skin.

SKU: AV3282770392791
-20%
21.20
€26.40

Pharmaceutical Care

Safe medication sales

Secure shipping

INFO AND TECHNICAL SPECIFICATIONS

Avene Sunisimed Pigment is an advanced sunscreen specifically designed for the protection and prevention of pigmentation spots on the skin. With a formula specially developed for sensitive skin, this product offers high sun protection with SPF50+, helping to prevent the damage caused by UV radiation that can trigger the appearance of dark spots on the skin.

This sunscreen not only protects against UVA and UVB rays, but also has antioxidant properties that help neutralise free radicals, which are responsible for premature skin ageing. Its light, fast-absorbing texture ensures a smooth and comfortable application, leaving no greasy residue or white effect on the skin.

In addition to its protective action, Avene Sunisimed Pigment also offers corrective benefits, thanks to the presence of active ingredients that help reduce the appearance of existing spots and prevent the formation of new ones. This cream helps to even skin tone and improve radiance, leaving a more radiant and even complexion.

Dermatologically tested and non-comedogenic, Avene Sunisimed Pigment is suitable for all skin types, including the most sensitive. Its hypoallergenic formula guarantees optimal tolerance, even on skin prone to allergic reactions. It is also fragrance-free and water-resistant, making it the perfect ally for protecting the skin during prolonged exposure to the sun.

Tecnical specifications card

Pharmaceutical advice

You can now consult our team with any questions you may have. We remind you that our chatbot is also available for simpler queries.

Ask us
Newsletter

Don’t miss anything

Stay up to date with the latest advances in health, discounts, and pharmaceutical news.